ObjectivesThe aim of this study was to compare the acute performance of the PLLA ABSORB bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) with second-generation metal drug-eluting stents (DES) in complex coronary artery lesions.BackgroundThick polymer-based BVS have different mechanical properties than thin second-generation DES. Data on the acute performance of BVS are limited to simple coronary lesions treated in trials with strict inclusion criteria.MethodsFifty complex coronary lesions (all type American College of Cardiology/American Heart Association B2-C) treated with a BVS undergoing a final optical coherence tomography (OCT) examination were compared with an equal number of matched lesions treated wit...
OBJECTIVES This study sought to describe the frequency and clinical impact of acute scaffold disr...
Recent clinical trials have raised concerns about the safety and efficacy of ABSORB™ bioresorbable v...
AIMS The Absorb bioresorbable vascular scaffold (Absorb BVS) provides similar clinical outcomes c...
Objectives The aim of this study was to compare the acute performance of the PLLA ABSORB bioresorbab...
ObjectivesThe aim of this study was to compare the acute performance of the PLLA ABSORB bioresorbabl...
Aims: Fully bioresorbable Absorb poly-L-lactic-acid (PLLA) scaffolds (Abbott Vascular, Santa Clara, ...
23siAims: This study aimed to compare the acute expansion behaviour of a polymer-based bioresorbable...
Percutaneous coronary intervention (PCI) which involves the deployment of devices such as metallic d...
No medium-term data are available on the random comparison between everolimus-eluting bioresorbable ...
BACKGROUND: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential impro...
Objectives The aim of this study was to demonstrate that the prevention of early scaffold area shrin...
BACKGROUND No medium-term data are available on the random comparison between everolimus-eluting ...
Aims Theoretically, bioresorbable vascular scaffolds (BVSs) may provide superior long-term results c...
BACKGROUND: Although previous observational studies have documented late luminal enlargement and exp...
Background: The newer generation of Bioresorbable Vascular Scaffold ABSORB (BVS 1.1) showed better o...
OBJECTIVES This study sought to describe the frequency and clinical impact of acute scaffold disr...
Recent clinical trials have raised concerns about the safety and efficacy of ABSORB™ bioresorbable v...
AIMS The Absorb bioresorbable vascular scaffold (Absorb BVS) provides similar clinical outcomes c...
Objectives The aim of this study was to compare the acute performance of the PLLA ABSORB bioresorbab...
ObjectivesThe aim of this study was to compare the acute performance of the PLLA ABSORB bioresorbabl...
Aims: Fully bioresorbable Absorb poly-L-lactic-acid (PLLA) scaffolds (Abbott Vascular, Santa Clara, ...
23siAims: This study aimed to compare the acute expansion behaviour of a polymer-based bioresorbable...
Percutaneous coronary intervention (PCI) which involves the deployment of devices such as metallic d...
No medium-term data are available on the random comparison between everolimus-eluting bioresorbable ...
BACKGROUND: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential impro...
Objectives The aim of this study was to demonstrate that the prevention of early scaffold area shrin...
BACKGROUND No medium-term data are available on the random comparison between everolimus-eluting ...
Aims Theoretically, bioresorbable vascular scaffolds (BVSs) may provide superior long-term results c...
BACKGROUND: Although previous observational studies have documented late luminal enlargement and exp...
Background: The newer generation of Bioresorbable Vascular Scaffold ABSORB (BVS 1.1) showed better o...
OBJECTIVES This study sought to describe the frequency and clinical impact of acute scaffold disr...
Recent clinical trials have raised concerns about the safety and efficacy of ABSORB™ bioresorbable v...
AIMS The Absorb bioresorbable vascular scaffold (Absorb BVS) provides similar clinical outcomes c...